The nurse evaluates a client's response to the prescribed atorvastatin. Which finding indicates an expected outcome?

A) Total cholesterol 198 mg/dL: While this value is within normal limits, it does not specifically indicate the effectiveness of atorvastatin treatment, which primarily aims to lower LDL levels. An optimal outcome would focus more on the LDL reduction rather than total cholesterol alone. B) Low density lipoprotein (LDL) 90 mg/dL: This finding indicates an expected outcome of atorvastatin therapy. Atorvastatin is effective at lowering LDL cholesterol, which is a key target in managing hyperlipidemia and reducing the risk of cardiovascular events. An LDL level below 100 mg/dL is generally considered optimal. C) Serum albumin 6 g/L: This value is low and indicates potential malnutrition or liver dysfunction, which are not expected outcomes for a client on atorvastatin. A normal serum albumin level typically ranges from 3.5 to 5.0 g/dL, so this finding is concerning. D) Alanine aminotransferase (ALT) 25 units/L: While this ALT level is within the normal range, it does not directly reflect the primary goal of atorvastatin therapy, which is to lower LDL cholesterol. Monitoring liver enzymes is important, but the expected outcome would be more clearly indicated by improved lipid profiles, particularly LDL levels.